China OKs Seaweed-Based Alzheimer’s Treatment
China’s drug safety agency has approved the sale of the new Alzheimer’s drug, called Oligomannate, which uses seaweed to treat mild to moderate forms of the cognitive disorder.
Read Original Article: China OKs Seaweed-Based Alzheimer’s Treatment »
